DJIA 17,550.69 -47.51 -0.27%
NASDAQ 5,105.55 -9.84 -0.19%
S&P 500 2,093.32 -4.72 -0.22%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

140.30 3.31 (2.42%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRTX $140.30 2.42%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $137.81
Previous Close $136.99
Daily Range $137.13 - $141.84
52-Week Range $84.41 - $141.84
Market Cap $34.2B
P/E Ratio -46.12
Dividend (Yield) $0.00 (0.0%)
Volume 2,011,059
Average Daily Volume 1,774,622
Current FY EPS -$2.00

Sector

Healthcare

Industry

Drug Makers

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

News & Commentary

Vertex Pharmaceuticals Rolls Along

Solid quarter, but Orkambi sales in future quarters will dictate the biotech’s fate.

3 Stocks Boosting The Drugs Industry Higher

3 Potential Huge Takeover Targets in Biotech

Vertex Posts Wider Y/Y Loss but Raises Kalydeco Outlook - Analyst Blog

3 Drugs Stocks Pushing Industry Growth

Vertex Pharmaceuticals (VRTX) Earnings Report: Q2 2015 Conference Call Transcript

Vertex Pharmaceuticals (VRTX) Jeffrey M. Leiden on Q2 2015 Results - Earnings Call Transcript

Trade-Ideas: Vertex Pharmaceuticals (VRTX) Is Today's Post-Market Leader Stock

Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst

Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst Blog

Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 66.7% Follow-Through Indicator, 3.8%

Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 66.7% Follow-Through Indicator, 3.8% Sensitive

See More VRTX News...

VRTX's Top Competitors

VRTX $140.30 (2.42%)
Current stock: VRTX
AMGN $174.80 (-0.45%)
Current stock: AMGN
GILD $118.87 (-0.61%)
Current stock: GILD
BIIB $330.38 (1.85%)
Current stock: BIIB